...Kehinde S. Okunade; Kabir B. Badmos; Adaiah P. Soibi-Harry; Sunusi-Rimi Garba; Ephraim O. Ohazurike; Oluchi Ozonu; Alani S. Akanmu; Folasade T. Ogunsola; Fatimah B. Abdulkareem; Rose I. Anorlu Introduction: As it may not be feasible to provide cervical cancer screening services to all HIV-infected...

..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2023 Cytology Cytopathology Gynecologic malignancies Cervical cancer HPV...

...Julieta E. Barroeta Background: Up until recently, cervical cytology was the mainstay for cervical cancer screening. However, the established association between human papillomavirus (HPV) infection and cervical cancer has led to changes in preventive strategies, with cytology being replaced...

..., instructions or products referred to in the content or advertisements. 2022 Human papillomavirus Conization Cervical cancer Screening Pre-cancer treatment Cervical cancer remains the fourth most common gynecologic malignancy worldwide, and its incidence continues to increase in Japan [ 1, 2...

...Yulin Guo; Qiuzi Peng; Ying Wang; Lu Li; Xiaoyun Yi; Bin Yan; Miao Zou; Guohong Dai; Peng Guo; Quanfu Ma; Xufeng Wu Objective: The objective of this study was to evaluate the application of DNA ploidy analysis in large-scale population screening for cervical cancer. Methods: From March 2016...

...Henrik Edvardsson; Jiangrong Wang; Bengt Andrae; Pär Sparén; Björn Strander; Joakim Dillner Sweden has experienced an unexpected >30% increase in cervical cancer incidence among women with normal cytological screening results. We therefore performed a nationwide assessment of false-negative...

... cervical histopathologic results. Using our continuously updated Bayesian cervical cancer screening model which includes clinical data, cervical screening results, and cervical biopsy results, we projected quantitative estimates of patients’ 5-year cumulative risk for cervical AIS or AdCa. Results: 161...

...Haitham Kussaibi; Reem Al Dossary; Ayesha Ahmed; Aroub Muammar; Raghad Aljohani Introduction: High-risk human papillomavirus (HR HPV) is found to be responsible for 4.5% of cancer in general, primarily cervical cancer. We aim here to highlight the prevalence and genotypes of HR HPV and correlate...

... seems to be aberrant in several forms of cancer. The purpose of the present systematic review is to evaluate the impact of PIK3CA mutations on survival outcomes of patients with cervical cancer. Methods: We used the Medline (1966–2020), Scopus (2004–2020), ClinicalTrials.gov (2008–2020), EMBASE (1980...

... and reliable information on YouTube videos about the Pap smear test, which is important for early detection of cervical cancers. While preparing health-related videos for YouTube and similar websites, the support of professional healthcare workers will help provide more accurate content. aligursoy44...

...Katia Ramos Moreira Leite; Ruan Pimenta; Juliana Canavez; Flavio Canavez; Fernando R. de Souza; Ligia Vara; Carmen Estivallet; Luiz Heraldo Camara-Lopes Background: Nearly 500,000 new cases of cervical cancer are estimated annually worldwide. Three vaccines are currently licensed to prevent...

...Bernhard Reinhold Mangold Objective: In order to increase overall participation in cervical cancer screening, several investigators propose a concept of introducing self-tests. The study presented here compared test results of the Pap test and 4 different HPV test systems of self-collected...

..., cervical cancer continues to be an important clinical and societal burden. Additionally, other HPV-associated cancers, for which there are no screening programmes, are rising. Finally, the optimal combination of vaccination and screening strategies will require careful thinking. Considering...

...Anna Paaso; Anna Jaakola; Stina Syrjänen; Karolina Louvanto Persistent high-risk human papillomavirus (HPV) infection has been associated with increased risk for cervical precancerous lesions and cancer. The host’s genetic variability is known to play a role in the development of cervical cancer...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Cervical cancer Cervical smears Screening Quality control Cervical cytology is the method used worldwide to screen for cervical cancer. It is inexpensive...

... of the prevention of cervical cancer by these HPV vaccines still awaits confirmation, and the same applies to the eventual prevention of human cancers at other anatomic sites, part of the global burden of oncogenic HPVs. kari.syrjanen@biohit.fi 3 05 2017 9 05 2017 11 7 2017 © 2017 S...

... screening in Japan which has contributed greatly in decreasing mortality from cervical cancers. osamura@iuhw.ac.jp 24 05 2017 29 05 2017 11 7 2017 © 2017 S. Karger AG, Basel 2017 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication...

... methylation in cervical cancers and high-grade CIN (CIN2 and CIN3), most prominently CADM1, EPB41L3, FAM19A4, MAL, miR-124, PAX1 and SOX1. Obtaining consistent performance data from the literature is quite difficult because most methylation studies used a variety of different assay methodologies and had...

...Christine Bergeron; Magnus von Knebel Doeberitz Objectives: Cervical cancer screening test performance has been hampered by either a lack of sensitivity in Pap cytology or a lack of specificity of human papillomavirus (HPV) testing. This is disturbing for patients and a cause of high costs...

...Cristina Mendes de Oliveira; José Eduardo Levi Human papillomaviruses (HPVs) are the etiologic agents of cervical cancer, the unique human neoplasia that has one single necessary cause. The diversity of HPVs is well described, with 200 HPV types existing as distinct taxonomic units and each...